<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04547959</url>
  </required_header>
  <id_info>
    <org_study_id>2102</org_study_id>
    <nct_id>NCT04547959</nct_id>
  </id_info>
  <brief_title>Retro-prospective Clinical Study to Evaluate the Efficacy of the Stand-alone Cervical Interbody Cage C-CURVE (Peek and Titanium) Manufactured by MEDICREA®</brief_title>
  <acronym>C-CURVE</acronym>
  <official_title>Retro-prospective Clinical Study to Evaluate the Efficacy of the Stand-alone Cervical Interbody Cage C-CURVE (Peek and Titanium) Manufactured by MEDICREA®</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Medicrea International</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Medicrea International</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      This study includes one type of product named C-CURVE which is a Stand-alone Cervical&#xD;
      Interbody Cage. This product is available in two materials: PEEK and Titanium.&#xD;
&#xD;
      The C-Curve Cervical Interbody Devices is one single implant used for insertion between two&#xD;
      adjacent vertebrae (cervical spine). C-Curve has been designed to restore and/or maintain&#xD;
      adequate interbody height, and thus help stabilize one or more cervical levels while fusion&#xD;
      occurs. This system has also as objectives to increase of the quality of life, decrease&#xD;
      patient's pain and decrease a potential dysphagia (clinical performances). This system must&#xD;
      only be used in the cervical spine.&#xD;
&#xD;
      This post-market clinical follow-up (PMCF) study aims to confirm the acceptable benefits/risk&#xD;
      profile of the device for the patients and to fill essential requirements to maintain the CE&#xD;
      mark through a clinical evaluation.&#xD;
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">November 20, 2020</start_date>
  <completion_date type="Anticipated">December 1, 2023</completion_date>
  <primary_completion_date type="Anticipated">December 1, 2023</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Non-Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <intervention_model_description>Retro-prospective, multicenter, non-comparative and interventional post market clinical follow-up</intervention_model_description>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Fusion of the cervical interbody cage used</measure>
    <time_frame>24 months</time_frame>
    <description>Measures the bone fusion thanks to the CTscan</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Fusion of the cervical interbody cage used</measure>
    <time_frame>6, 12 and 24 months</time_frame>
    <description>Measures the bone fusion thanks to the Xrays</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Quality of life with SF-12</measure>
    <time_frame>Preoperative, and 6, 12 and 24 months postoperative</time_frame>
    <description>Score of the SF-12 (to 0 (better) to 100 (worst)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Satisfaction patient</measure>
    <time_frame>6, 12 and 24 months</time_frame>
    <description>Score of the PSI (scale: 1/2/3/4 ; 1: Better)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>VAS (Pain)</measure>
    <time_frame>Preoperative, and 6, 12 and 24 months postoperative</time_frame>
    <description>Score of the pain (to 0 (better) to 10 (worst)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>NDI(Neck Disability Index)</measure>
    <time_frame>Preoperative, and 6, 12 and 24 months postoperative</time_frame>
    <description>Score of the pain (to 0 (better) to 50 (worst)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Cervical spinal radiographic parameters (Cobb angle, C2C7 angle, Segmental lordosis/kyphosis, disk height, subsidence, alignment restauration ) for C-CURVE Titanium only</measure>
    <time_frame>Preoperative, and 6, 12 and 24 months postoperative</time_frame>
    <description>radiographic measurements</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Complications</measure>
    <time_frame>peroperative and 6, 12 and 24 months postoperative</time_frame>
    <description>list all complications to calculate the rate of intraoperative and postoperative complications</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">146</enrollment>
  <condition>C-CURVE , Cervical Interbody Cage</condition>
  <condition>Cervical Disc Disease</condition>
  <condition>Cervical Discopathy</condition>
  <arm_group>
    <arm_group_label>C-CURVE PEEK</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>According the routine practice of the investigator surgeon, the interbody cage C-CURVE in PEEK or Titane is used</description>
  </arm_group>
  <arm_group>
    <arm_group_label>C-CURVE Titane</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>According the routine practice of the investigator surgeon, the interbody cage C-CURVE in PEEK or Titane is used</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>cervical interbody cage C-CURVE</intervention_name>
    <description>ACDF: Anterior Cervical Discectomy and Fusion with a C-CURVE cage (in PEEK or Titanium)</description>
    <arm_group_label>C-CURVE PEEK</arm_group_label>
    <arm_group_label>C-CURVE Titane</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Patient operated with C-CURVE PEEK or C-CURVE TITANIUM (MEDICREA) for one or several&#xD;
             levels (3 maximum)&#xD;
&#xD;
          -  Cage implanted with the bone graft &quot;OSMOSYS&quot; (MEDICREA) or an auto bone graft from&#xD;
             patients&#xD;
&#xD;
          -  Patient ≥ 18 years&#xD;
&#xD;
          -  Patient affiliated to health care insurance (social security in France)&#xD;
&#xD;
          -  Patient who signed an informed consent form&#xD;
&#xD;
          -  Patient able and willing to complete a self-administered questionnaire&#xD;
&#xD;
          -  Patient able to understand protocol and the planning visit and willing to perform all&#xD;
             of them&#xD;
&#xD;
          -  Patient with a pathology indicated in the instruction for use of the implant&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Patient with no preoperative data available (X-rays, questionnaires)&#xD;
&#xD;
          -  Hybrid installation or cervical additional fixation&#xD;
&#xD;
          -  Patient contraindicated for X-ray(s) and/or CT-Scan(s)&#xD;
&#xD;
          -  Patient with contraindications indicated in the instruction for use of the implant&#xD;
&#xD;
          -  Patient judged as non-compliant by the investigator, not unable to come back for the&#xD;
             follow-up visits (for example: patient living more than 100 km away).&#xD;
&#xD;
          -  Patient who declined to participate to the study or unable to give his consent&#xD;
             Vulnerable population as explained in the protocol&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_contact>
    <last_name>Caroline Leblanc</last_name>
    <phone>0472018787</phone>
    <email>clinicalstudy@medicrea.com</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Carole Bergougnoux</last_name>
    <phone>0472018787</phone>
    <email>clinicalstudy@medicrea.com</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>CH WAPI</name>
      <address>
        <city>Tournai</city>
        <country>Belgium</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Michel Triffaux, MD</last_name>
    </contact>
    <investigator>
      <last_name>Michel Triffaux, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Triantafyllos Bouras, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Jordan Assaker</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Clinique d'Argonay</name>
      <address>
        <city>Argonay</city>
        <country>France</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <investigator>
      <last_name>Manuel MD Lopez</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Clinique Belharra</name>
      <address>
        <city>Bayonne</city>
        <country>France</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <investigator>
      <last_name>Jean MD Bernard</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Clinique du Parc</name>
      <address>
        <city>Castelnau-le-Lez</city>
        <country>France</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Martin Grau-Ortiz</last_name>
    </contact>
    <investigator>
      <last_name>Martin MD Grau-Ortiz</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Groupe Hospitalier La Rochelle-Re-Aunis</name>
      <address>
        <city>La Rochelle</city>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <investigator>
      <last_name>Mathieu Md Saget</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Centre de consultations spécialisées de la Sauvegarde</name>
      <address>
        <city>Lyon</city>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <investigator>
      <last_name>Alexandre MD Delmotte</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Centre Médico-Chirurgical de Réadaptation des Massues</name>
      <address>
        <city>Lyon</city>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <investigator>
      <last_name>Alice MD Darnis</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Centre Orthopédique Santy</name>
      <address>
        <city>Lyon</city>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Henri MD D'Astorg</last_name>
    </contact>
    <investigator>
      <last_name>Marc Szadkowki</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Henri D'Astorg</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Clinique Clairval</name>
      <address>
        <city>Marseille</city>
        <country>France</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <investigator>
      <last_name>Ferracci François-Xavier</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>CHU - Pasteur II</name>
      <address>
        <city>Nice</city>
        <country>France</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <investigator>
      <last_name>Nicolas MD Bronsard</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Hôpital Charles Nicolle CHU Rouen</name>
      <address>
        <city>Rouen</city>
        <country>France</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <investigator>
      <last_name>Piere MD Hannequin</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Clinique de l'Union</name>
      <address>
        <city>Saint-Jean</city>
        <zip>31240</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <investigator>
      <last_name>Alexis MD Perez</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>CHRU Bretonneau</name>
      <address>
        <city>Tours</city>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <investigator>
      <last_name>Aymeric MD Amelot</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>Belgium</country>
    <country>France</country>
  </location_countries>
  <reference>
    <citation>Alimi M, Njoku I, Hofstetter CP, Tsiouris AJ, Kesavabhotla K, Boockvar J, Navarro-Ramirez R, Härtl R. Anterior Cervical Discectomy and Fusion (ACDF): Comparison Between Zero Profile Implants and Anterior Cervical Plate and Spacer. Cureus. 2016 Apr 17;8(4):e573. doi: 10.7759/cureus.573.</citation>
    <PMID>27200226</PMID>
  </reference>
  <reference>
    <citation>Azab W, Abdel-Razek M, Ali A, Abdelrahman A, Salaheldin W, Nasim K, Attia H, Soliman D. Outcome evaluation of a zero-profile implant for anterior cervical diskectomy with fusion. Turk Neurosurg. 2012;22(5):611-7. doi: 10.5137/1019-5149.JTN.5646-11.2.</citation>
    <PMID>23015339</PMID>
  </reference>
  <reference>
    <citation>Barbagallo GM, Romano D, Certo F, Milone P, Albanese V. Zero-P: a new zero-profile cage-plate device for single and multilevel ACDF. A single institution series with four years maximum follow-up and review of the literature on zero-profile devices. Eur Spine J. 2013 Nov;22 Suppl 6:S868-78. doi: 10.1007/s00586-013-3005-0. Epub 2013 Sep 24. Review.</citation>
    <PMID>24061968</PMID>
  </reference>
  <reference>
    <citation>Bucci MN, Oh D, Cowan RS, Davis RJ, Jackson RJ, Tyndall DS, Nehls D. The ROI-C zero-profile anchored spacer for anterior cervical discectomy and fusion: biomechanical profile and clinical outcomes. Med Devices (Auckl). 2017 Apr 18;10:61-69. doi: 10.2147/MDER.S127133. eCollection 2017.</citation>
    <PMID>28458586</PMID>
  </reference>
  <reference>
    <citation>Chen Y, Liu Y, Chen H, Cao P, Yuan W. Comparison of Curvature Between the Zero-P Spacer and Traditional Cage and Plate After 3-Level Anterior Cervical Discectomy and Fusion: Mid-term Results. Clin Spine Surg. 2017 Oct;30(8):E1111-E1116. doi: 10.1097/BSD.0000000000000440.</citation>
    <PMID>27642818</PMID>
  </reference>
  <reference>
    <citation>De Leo-Vargas RA, Muñoz-Romero I, Mondragón-Soto MG, Martínez-Anda JJ. Locking Stand-Alone Cage Constructs for the Treatment of Cervical Spine Degenerative Disease. Asian Spine J. 2019 Apr 10;13(4):630-637. doi: 10.31616/asj.2018.0234. Print 2019 Aug.</citation>
    <PMID>30962412</PMID>
  </reference>
  <reference>
    <citation>Lee YS, Kim YB, Park SW. Does a zero-profile anchored cage offer additional stabilization as anterior cervical plate? Spine (Phila Pa 1976). 2015 May 15;40(10):E563-70. doi: 10.1097/BRS.0000000000000864.</citation>
    <PMID>25955093</PMID>
  </reference>
  <reference>
    <citation>Li Z, Zhao Y, Tang J, Ren D, Guo J, Wang H, Li L, Hou S. A comparison of a new zero-profile, stand-alone Fidji cervical cage and anterior cervical plate for single and multilevel ACDF: a minimum 2-year follow-up study. Eur Spine J. 2017 Apr;26(4):1129-1139. doi: 10.1007/s00586-016-4739-2. Epub 2016 Aug 23.</citation>
    <PMID>27554353</PMID>
  </reference>
  <reference>
    <citation>Lu Y, Bao W, Wang Z, Zhou F, Zou J, Jiang W, Yang H, Zhang Z, Zhu X. Comparison of the clinical effects of zero-profile anchored spacer (ROI-C) and conventional cage-plate construct for the treatment of noncontiguous bilevel of cervical degenerative disc disease (CDDD): A minimum 2-year follow-up. Medicine (Baltimore). 2018 Feb;97(5):e9808. doi: 10.1097/MD.0000000000009808.</citation>
    <PMID>29384883</PMID>
  </reference>
  <reference>
    <citation>Nambiar M, Phan K, Cunningham JE, Yang Y, Turner PL, Mobbs R. Locking stand-alone cages versus anterior plate constructs in single-level fusion for degenerative cervical disease: a systematic review and meta-analysis. Eur Spine J. 2017 Sep;26(9):2258-2266. doi: 10.1007/s00586-017-5015-9. Epub 2017 Mar 10. Review.</citation>
    <PMID>28283840</PMID>
  </reference>
  <reference>
    <citation>Scholz M, Schelfaut S, Pingel A, Schleicher P, Kandziora F. A cervical &quot;zero-profile&quot; cage with integrated angle-stable fixation: 24-months results. Acta Orthop Belg. 2014 Dec;80(4):558-66.</citation>
    <PMID>26280730</PMID>
  </reference>
  <verification_date>September 2020</verification_date>
  <study_first_submitted>September 7, 2020</study_first_submitted>
  <study_first_submitted_qc>September 7, 2020</study_first_submitted_qc>
  <study_first_posted type="Actual">September 14, 2020</study_first_posted>
  <last_update_submitted>December 2, 2020</last_update_submitted>
  <last_update_submitted_qc>December 2, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">December 3, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>cervical disc disease</keyword>
  <keyword>cervical disc degeneration</keyword>
  <keyword>C-CURVE , cervical interbody cage</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Intervertebral Disc Displacement</mesh_term>
    <mesh_term>Intervertebral Disc Degeneration</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

